BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8695540)

  • 1. Somatic genetic changes in lung cancer and precancerous lesions.
    Sundaresan V; Heppell-Parton A; Coleman N; Miozzo M; Sozzi G; Ball R; Cary N; Hasleton P; Fowler W; Rabbitts P
    Ann Oncol; 1995; 6 Suppl 1():27-31; discussion 31-2. PubMed ID: 8695540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.
    Sundaresan V; Ganly P; Hasleton P; Rudd R; Sinha G; Bleehen NM; Rabbitts P
    Oncogene; 1992 Oct; 7(10):1989-97. PubMed ID: 1408139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.
    Thiberville L; Payne P; Vielkinds J; LeRiche J; Horsman D; Nouvet G; Palcic B; Lam S
    Cancer Res; 1995 Nov; 55(22):5133-9. PubMed ID: 7585560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.
    Hung J; Kishimoto Y; Sugio K; Virmani A; McIntire DD; Minna JD; Gazdar AF
    JAMA; 1995 Feb; 273(7):558-63. PubMed ID: 7837389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
    Sozzi G; Miozzo M; Donghi R; Pilotti S; Cariani CT; Pastorino U; Della Porta G; Pierotti MA
    Cancer Res; 1992 Nov; 52(21):6079-82. PubMed ID: 1394234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
    Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
    Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
    Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C
    Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions.
    Sozzi G; Miozzo M; Pastorino U; Pilotti S; Donghi R; Giarola M; De Gregorio L; Manenti G; Radice P; Minoletti F
    Cancer Res; 1995 Jan; 55(1):135-40. PubMed ID: 7805023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
    Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients.
    Smith AL; Hung J; Walker L; Rogers TE; Vuitch F; Lee E; Gazdar AF
    Br J Cancer; 1996 Jan; 73(2):203-9. PubMed ID: 8546907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential molecular genetic changes in lung cancer development.
    Chung GT; Sundaresan V; Hasleton P; Rudd R; Taylor R; Rabbitts PH
    Oncogene; 1995 Dec; 11(12):2591-8. PubMed ID: 8545116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
    Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
    Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
    Keith RL; Miller YE; Gemmill RM; Drabkin HA; Dempsey EC; Kennedy TC; Prindiville S; Franklin WA
    Clin Cancer Res; 2000 May; 6(5):1616-25. PubMed ID: 10815878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung carcinoma-associated atypical adenomatoid hyperplasia, squamous cell dysplasia, and chromosome alterations in non-neoplastic bronchial mucosa.
    Kayser K; Kosjerina Z; Goldmann T; Kayser G; Kazmierczak B; Vollmer E
    Lung Cancer; 2005 Feb; 47(2):205-14. PubMed ID: 15639719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.